Note 12 - Subsequent Events (Details Textual) - Subsequent Event [Member] - USD ($) $ in Millions |
Feb. 01, 2018 |
Jan. 02, 2018 |
|---|---|---|
| Atlanta Biologicals [Member] | ||
| Business Combination, Consideration Transferred | $ 50.0 | |
| Eurocell Diagnostics, SAS [Member] | ||
| Business Combination, Consideration Transferred | $ 7.5 |
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|